UPDATE
: Monday, September 7, 2020
Home
Login
Mobile Version
All
Hospital
Pharma
Bio
Korea‘s Bio Industry
Device/ICT
Policy
People
Life science
Special
Innovation for Survival
Korea’s medical culture series
Korea’s New Candidate Drug Watch List
Special Series in Celebration of KBR's 1st Anniversary
Interview with foreign envoys
Special Series in Celebration of KBR’s 2nd Anniversary
Interview with global pharma
Special Series in Celebration of KBR’s 3rd Anniversary
Special Series in Celebration of KBR’s 4th Anniversary
ASCO 2020 Highlights
Opinion
Reporter’s Notebook
Search
트위터
페이스북
RSS
상단여백
제목보기
제목보기
제목+내용
Jeil releases P3 clinical trial results for anti-hypertension treatment
Jeil Pharmaceutical said Monday that it has published the phase 3 clinical ...
by Lee Han-soo
|
2019-03-11 14:03
라인
Officials to visit Gore to get artificial blood vessels for children
Korean health officials said they would soon visit the headquarters of W.L....
by Lee Hye-seon
|
2019-03-11 11:20
라인
ResMed acquires HB Healthcare
ResMed, a U.S.-based medical equipment company that primarily deals with eq...
by Lee Han-soo
|
2019-03-08 17:49
라인
Daewoong’s pulmonary fibrosis treatment wins government support
Daewoong Pharmaceutical said Friday that the Korea Drug Development Fund (K...
by Lee Han-soo
|
2019-03-08 16:57
라인
Yonsei, AITRICS to establish AI-based emergency prediction system
Yonsei University Health System (YUHS) said Thursday that it has signed an ...
by Lee Han-soo
|
2019-03-08 16:09
라인
Gilead, Yuhan to co-promote Biktarvy
Yuhan Corp. said Friday that it has signed an agreement with Gilead Science...
by Lee Han-soo
|
2019-03-08 15:32
라인
Secondhand smoke raises risk for chronic kidney disease
Exposure to secondhand smoke can elevate the risk for chronic kidney diseas...
by Lee Hye-seon
|
2019-03-08 15:31
라인
Roche Korea’s combo therapy gets nod as 1st-line lung cancer therapy
Roche Korea said Friday that its combination therapy -- Tecentriq and Alece...
by Lee Han-soo
|
2019-03-08 14:38
라인
17% of hospital workers confirmed with latent tuberculosis
About 17 percent of employees working at local medical institutions were co...
by Kwak Sung-sun
|
2019-03-08 14:36
라인
Sanofi Genzyme’s Gaucher disease treatment gets more insurance benefit
Sanofi Genzyme Korea, a subsidiary of Sanofi, said Thursday that the Minist...
by Lee Han-soo
|
2019-03-07 16:22
라인
Daewoong marks record-high sales in 2018
Daewoong Pharmaceutical said Wednesday that it recorded sales of 943.5 bill...
by Lee Han-soo
|
2019-03-07 16:01
라인
When will NOAC reversal agents be available in Korea?
Several drugs that reverse the blood thinning effect of non-vitamin K oral ...
by Kim Yun-mi
|
2019-03-07 15:52
라인
Off-label use of sirolimus for pediatric pulmonary vein stenosis banned
The government has banned the off-label use of sirolimus, an immunosuppress...
by Lee Hye-seon
|
2019-03-07 15:10
라인
Celltrion Healthcare wins biosimilar bids in SE Asia
Celltrion Healthcare said that it won the bids for Singapore’s infliximab b...
by Lee Han-soo
|
2019-03-07 14:25
라인
Amgen’s Xgeva solves adverse effect problems
Amgen’s Xgeva (ingredient: denosumab) has resolved adverse effect issues fo...
by Lee Han-soo
|
2019-03-07 14:25
라인
‘Korean drugmakers can tap US generic market’
Korean pharmaceutical companies would find it better to utilize long-accumu...
by Jeong Sae-im
|
2019-03-07 11:54
라인
SNUBH implements smart surgical system
Seoul National University Bundang Hospital (SNUBH) said that it has built a...
by Lee Han-soo
|
2019-03-06 17:37
라인
Foreign patients mostly satisfied with Korea’s healthcare service
International patients who received treatment at Korean medical institution...
by Lee Han-soo
|
2019-03-06 17:05
라인
Interagency new drug development project generates ₩7.3 trillion license deals
The government said the “pan-governmental full-cycle new drug development p...
by Kwak Sung-sun
|
2019-03-06 16:24
라인
EzCareTech to speed up global presence with IPO
EzCareTech expressed its aspiration to become a global health networking le...
by Lee Han-soo
|
2019-03-06 14:58
-
이전
141
142
143
144
145
-
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
여백
Most viewed
1
‘Cyramza helped improve gastric cancer treatment in Korea’
2
‘Reduced-dose prasugrel effective for ACS patients undergoing PCI’
3
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
4
SNUBH develops AI model predicting patients at risk of cerebral aneurysm
5
Novavax releases encouraging phase-1 results on Covid-19 vaccine candidate
6
LG Chem, SK Bioscience end sales partnership with Daewoong
7
UBcare wins patent for tech to monitor suspected infectious diseases
8
176 civic groups furious over government-doctors deal
9
Recovered Covid-19 patients suffer from aftereffects – for long
10
Regulator OKs JW Pharma's rheumarthritis drug for treating giant cell arteries
여백
Opinion
[Column] Correct diagnosis leads to proper treatment
[Column] How ongoing doctors’ strike is different from 20 years ago
A Korean-American Doctor asks: Is Korea truly in 2020?
여백
Back to Top